Resources
Blog: Read the latest post
Enabling every cure for community matters: Our AI-powered journey
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.
VibeCast: Expert interviews
VibeCast is our informational podcast and content series exploring the hottest topics in drug development.
Guests include biotech founders, regulatory experts, drug development executives, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.
Additional resources
In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey starting the company in 2014. Insilico Medicine’s mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Aging research and drug development
The pursuit of novel cures in the pharmaceutical industry has always been a challenging endeavor. However, within the last decade or so, the landscape has become even more complex and disruptive due to several key factors. In this blog, we explore four major disruptions impacting the hunt for new cures
“In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.”
In this episode, VibeCast host Ray Dogum speaks with Sandra Shpilberg, Co-founder and CEO of Adnexi, about using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch. The Importance of Collaboration in Drug Development In the pharmaceutical industry, collaboration plays
In this episode, VibeCast host Ray Dogum speaks with Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, about groundbreaking small molecule therapies for Duchenne muscular dystrophy. Frank Gleeson’s journey into the world of small molecule therapy for Duchenne muscular dystrophy is a testament to the power of unexpected paths and
Uncover new possibilities with VibeOne
Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.
